← Companies|Biogenesis Bago
Bi

Biogenesis Bago

Buenos Aires ARFounded 19922,000 employees
Private CapbiotechPrivateInfectious Disease
Platform: Veterinary Bio
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
IvoinavolisibBIO-4202Phase 2/32RadioligandCFTRTYK2iADHDCeliac
BIO-8234BIO-8234Preclinical1Bispecific AbJAK2EGFRiUrothelial CaFSGS
BIO-1735BIO-1735Phase 22ERTCl18.2FXIaiHNSCCADPKD
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)
2025-02-18
BIO-1735 Ph2 Data
HNSCC
Past
2025-05-17
BIO-8234 Interim
Urothelial Ca
Past
2028-10-09
Ivoinavolisib Ph3 Readout
ADHD
Ph3 Readout
2030-09-10
BIO-1735 Ph2 Data
HNSCC
Ph2 Data